An Optimized MNK1b Aptamer, apMNKQ2, and Its Potential Use as a Therapeutic Agent in Breast Cancer

The obtained aptamer, named apMNKQ2, was able to inhibit proliferation, colony formation, migration and invasion in breast cancer cells.